Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Asthma Patient Education in the Emergency Room
Trial of Asthma Patient Education in the Emergency Room
Status: Archived
Hospital for Special Surgery
mi
from
New York, NY
Asthma Patient Education in the Emergency Room
Trial of Asthma Patient Education in the Emergency Room
Status: Archived
Updated: 1/1/1970
Hospital for Special Surgery
mi
from
New York, NY
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
Mechanisms of Airway Inflammation: Natural Exacerbation of Asthma Induced by Glucocorticoid Withdrawal
Status: Archived
Washington University
mi
from
St. Louis, MO
Inflammatory Processes in the Airway of Asthmatics With Persistent Bronchial Hyperreactivity
Mechanisms of Airway Inflammation: Natural Exacerbation of Asthma Induced by Glucocorticoid Withdrawal
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy ( Lansoprazole; Solutab) in the Management of Childhood Asthma
Status: Archived
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
mi
from
Atlanta, GA
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy ( Lansoprazole; Solutab) in the Management of Childhood Asthma
Status: Archived
Updated: 1/1/1970
Children's Healthcare of Atlanta at Egleston - Pediatric Cardiac Intensive Care Unit
mi
from
Atlanta, GA
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy ( Lansoprazole; Solutab) in the Management of Childhood Asthma
Status: Archived
Georgia Pediatric Pulmonology Associates, P.C.
mi
from
Atlanta, GA
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy ( Lansoprazole; Solutab) in the Management of Childhood Asthma
Status: Archived
Updated: 1/1/1970
Georgia Pediatric Pulmonology Associates, P.C.
mi
from
Atlanta, GA
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy ( Lansoprazole; Solutab) in the Management of Childhood Asthma
Status: Archived
Children's Center for Digestive Healthcare
mi
from
Atlanta, GA
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.
A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy ( Lansoprazole; Solutab) in the Management of Childhood Asthma
Status: Archived
Updated: 1/1/1970
Children's Center for Digestive Healthcare
mi
from
Atlanta, GA
Problem-Solving Skills Training to Improve Care for Children With Asthma
Reducing Barriers to Care for Vulnerable Children With Asthma
Status: Archived
Children's Hospital/USC School of Medicine
mi
from
Los Angeles, CA
Problem-Solving Skills Training to Improve Care for Children With Asthma
Reducing Barriers to Care for Vulnerable Children With Asthma
Status: Archived
Updated: 1/1/1970
Children's Hospital/USC School of Medicine
mi
from
Los Angeles, CA
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
University of Alabama at Birmingham
mi
from
Birmingham, AL
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
University of Alabama at Birmingham
mi
from
Birmingham, AL
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
University of California at San Francisco (UCSF)
mi
from
San Francisco, CA
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
National Jewish Medical and Research Center
mi
from
Denver, CO
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
National Jewish Medical and Research Center
mi
from
Denver, CO
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Nemours Children's Clinic
mi
from
Jacksonville, FL
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
Nemours Children's Clinic
mi
from
Jacksonville, FL
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
University of Miami School of Medicine
mi
from
Miami, FL
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
University of Miami School of Medicine
mi
from
Miami, FL
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
University of South Floirda
mi
from
Tampa, FL
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
University of South Floirda
mi
from
Tampa, FL
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Emory Umiversity School of Medicine
mi
from
Atlanta, GA
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
Emory Umiversity School of Medicine
mi
from
Atlanta, GA
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Northwestern University
mi
from
Chicago, IL
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Indiana University
mi
from
Indianapolis, IN
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
Indiana University
mi
from
Indianapolis, IN
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
University of Minnesota Medical Center
mi
from
Minneapolis, MN
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
University of Missouri, Kansas City School of Medicine
mi
from
Kansas City, MO
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
University of Missouri, Kansas City School of Medicine
mi
from
Kansas City, MO
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Washington University
mi
from
St. Louis, MO
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
North Shore Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
North Shore Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
New York University Langone Medical Center
mi
from
New York, NY
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
New York University Langone Medical Center
mi
from
New York, NY
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
New York Medical College
mi
from
Valhalla, NY
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
New York Medical College
mi
from
Valhalla, NY
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Duke Univ Med Ctr
mi
from
Durham, NC
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
Duke Univ Med Ctr
mi
from
Durham, NC
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Davis Heart and Lung Research Institute
mi
from
Columbus, OH
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
Davis Heart and Lung Research Institute
mi
from
Columbus, OH
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Penn Presbyterain Medical Center/Penn Lung Center
mi
from
Philadelphia, PA
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
Penn Presbyterain Medical Center/Penn Lung Center
mi
from
Philadelphia, PA
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Baylor School of Medicine
mi
from
Houston, TX
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
Baylor School of Medicine
mi
from
Houston, TX
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
University of Vermont College of Medicine
mi
from
Burlington, VT
Lansoprazole to Treat Children With Asthma
Phase III: The Study of Acid Reflux in Children With Asthma
Status: Archived
Updated: 1/1/1970
University of Vermont College of Medicine
mi
from
Burlington, VT
Modification of Asthma With Soy Isoflavone
Modification of Asthma With Soy Isoflavone
Status: Archived
Northwestern University
mi
from
Chicago, IL
Modification of Asthma With Soy Isoflavone
Modification of Asthma With Soy Isoflavone
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Costimulation Inhibition in Asthma
Costimulation Inhibition in Asthma
Status: Archived
Washington University
mi
from
St. Louis, MO
Costimulation Inhibition in Asthma
Costimulation Inhibition in Asthma
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population
The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population
Status: Archived
Washington State University
mi
from
Pullman, WA
The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population
The Effects of Exercise on Physiological and Psychological Parameters in an Asthmatic Population
Status: Archived
Updated: 1/1/1970
Washington State University
mi
from
Pullman, WA
Improving Asthma Care Through Parental Empowerment
Improving Asthma Care Through Parental Empowerment: Effect on Healthcare Utilization and Parent Self-Efficacy
Status: Archived
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
Improving Asthma Care Through Parental Empowerment
Improving Asthma Care Through Parental Empowerment: Effect on Healthcare Utilization and Parent Self-Efficacy
Status: Archived
Updated: 1/1/1970
Children's Nutrition Research Center, Baylor College of Medicine
mi
from
Houston, TX
In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics
In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics
Status: Archived
Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics
In Vitro Basophil Responsiveness to Allergen Challenge After Gamma-tocopherol Supplementation in Allergic Asthmatics
Status: Archived
Updated: 1/1/1970
Center for Environmental Medicine, Asthma and Lung Biology
mi
from
Chapel Hill, NC
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Los Angeles County-USC Medical Center
mi
from
Los Angeles, CA
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
University of Southern California Women's and Children's Hospital
mi
from
Los Angeles, CA
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
University of Southern California Women's and Children's Hospital
mi
from
Los Angeles, CA
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Olive View - UCLA Medical Center
mi
from
Sylmar, CA
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
University of Colorado, Boulder
mi
from
Boulder, CO
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
University of Colorado, Boulder
mi
from
Boulder, CO
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Loyola University Medical Center
mi
from
Proviso, IL
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Loyola University Medical Center
mi
from
Proviso, IL
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Louisiana State University
mi
from
New Orleans, LA
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Louisiana State University
mi
from
New Orleans, LA
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Brigham & Women's Hospital Women's Health Center
mi
from
Chestnut Hill, MA
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Massachusetts General Hospital
mi
from
Boston, MA
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Massachusetts General Hospital
mi
from
Boston, MA
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Wayne State University
mi
from
Detroit, MI
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Wayne State University
mi
from
Detroit, MI
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Henry Ford Hospital
mi
from
Detroit, MI
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Henry Ford Hospital
mi
from
Detroit, MI
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Washington University
mi
from
St. Louis, MO
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Washington University
mi
from
St. Louis, MO
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Cooper University Hospital
mi
from
Camden, NJ
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Cooper University Hospital
mi
from
Camden, NJ
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Hackensack University
mi
from
Hackensack, NJ
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Hackensack University
mi
from
Hackensack, NJ
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
New York Methodist Hospital
mi
from
Brooklyn, NY
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
New York Methodist Hospital
mi
from
Brooklyn, NY
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Jamaica Hospital Medical Center
mi
from
Jamaica, NY
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Jamaica Hospital Medical Center
mi
from
Jamaica, NY
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
New York Hospital
mi
from
Queens, NY
Study Evaluating the Safety and Efficacy of MN-221 as an Adjunct to Standard Therapy in Subjects Experiencing an Acute Exacerbation of Asthma
MN-221-CL-007: A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of MN-221 When Administered Intravenously as an Adjunct to Standard Therapy to Adults With an Acute Exacerbation of Asthma
Status: Archived
Updated: 1/1/1970
New York Hospital
mi
from
Queens, NY